MetLife, Inc. (NYSE:MET) Shares Bought by Fiduciary Trust Co.

Fiduciary Trust Co. boosted its position in shares of MetLife, Inc. (NYSE:MET) by 46.2% during the first quarter, according to its most recent filing with the SEC. The fund owned 10,497 shares of the financial services provider’s stock after buying an additional 3,316 shares during the period. Fiduciary Trust Co.’s holdings in MetLife were worth $555,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in MET. Atria Investments LLC boosted its stake in MetLife by 2.6% in the first quarter. Atria Investments LLC now owns 18,914 shares of the financial services provider’s stock worth $999,000 after buying an additional 488 shares in the last quarter. Prospera Financial Services Inc purchased a new stake in MetLife during the first quarter worth about $1,525,000. Teacher Retirement System of Texas boosted its stake in MetLife by 7.2% in the first quarter. Teacher Retirement System of Texas now owns 822,785 shares of the financial services provider’s stock worth $43,460,000 after buying an additional 55,508 shares in the last quarter. Tompkins Financial Corp boosted its stake in MetLife by 40.8% in the first quarter. Tompkins Financial Corp now owns 7,789 shares of the financial services provider’s stock worth $342,000 after buying an additional 2,258 shares in the last quarter. Finally, Aberdeen Asset Management PLC UK boosted its stake in MetLife by 1.3% in the first quarter. Aberdeen Asset Management PLC UK now owns 469,645 shares of the financial services provider’s stock worth $24,807,000 after buying an additional 6,188 shares in the last quarter. Institutional investors and hedge funds own 75.61% of the company’s stock.

Shares of MetLife, Inc. (NYSE:MET) opened at 47.02 on Friday. MetLife, Inc. has a 52-week low of $40.08 and a 52-week high of $58.09. The company has a market cap of $49.98 billion, a P/E ratio of 553.18 and a beta of 1.46. The stock’s 50 day moving average price is $48.77 and its 200-day moving average price is $51.47.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.28 by $0.02. MetLife had a return on equity of 8.51% and a net margin of 0.30%. The company had revenue of $17.39 billion for the quarter, compared to the consensus estimate of $17.11 billion. During the same quarter last year, the business posted $0.83 EPS. MetLife’s revenue for the quarter was up 2.5% on a year-over-year basis. Equities analysts expect that MetLife, Inc. will post $4.88 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 13th. Investors of record on Monday, August 7th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 3.40%. The ex-dividend date of this dividend is Thursday, August 3rd. MetLife’s dividend payout ratio (DPR) is 1,777.98%.

COPYRIGHT VIOLATION NOTICE: “MetLife, Inc. (NYSE:MET) Shares Bought by Fiduciary Trust Co.” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.com-unik.info/2017/08/19/fiduciary-trust-co-buys-3316-shares-of-metlife-inc-nysemet-updated-updated.html.

Several analysts recently commented on the company. Langen Mcalenn reaffirmed a “buy” rating on shares of MetLife in a research note on Wednesday. Barclays PLC decreased their price target on MetLife from $67.00 to $60.00 and set an “overweight” rating on the stock in a research note on Friday, August 11th. ValuEngine raised MetLife from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 11th. Zacks Investment Research lowered MetLife from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Finally, BidaskClub raised MetLife from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th. Two analysts have rated the stock with a sell rating, six have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. MetLife currently has an average rating of “Buy” and a consensus price target of $59.17.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Institutional Ownership by Quarter for MetLife (NYSE:MET)

What are top analysts saying about MetLife Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MetLife Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit